Stay updated on Trigriluzole With Immunotherapy in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Trigriluzole With Immunotherapy in Solid Tumors Clinical Trial page.

Latest updates to the Trigriluzole With Immunotherapy in Solid Tumors Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedEnrollment status now shows No longer looking for participants, and new user guidance sections How to Read a Study Record, Common Questions, and How to Join a Study have been added to help users understand and engage with the study. The label for Intervention/Treatment has been updated (Intervention / Treatment removed) and a Revision: v3.6.0 note is introduced, replacing the previous v3.5.5 reference.SummaryDifference0.4%

- Check17 days agoChange DetectedThe footer now shows Revision: v3.5.5, replacing Revision: v3.5.4. This reflects a minor platform update to the site's software version rather than a content change.SummaryDifference0.0%

- Check38 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing the previous revision label. This reflects a minor update to the record's versioning metadata without changing substantive content.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page’s footer revision label was updated from v3.5.2 to v3.5.3, reflecting a site/software release rather than a change to the clinical trial information.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page shows a revision update from v3.5.0 to v3.5.2 (footer/site metadata update).SummaryDifference0.0%

- Check81 days agoChange DetectedAdded 'Squamous cell carcinoma of the head and neck' to the study's listed conditions.SummaryDifference0.0%

Stay in the know with updates to Trigriluzole With Immunotherapy in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Trigriluzole With Immunotherapy in Solid Tumors Clinical Trial page.